A Polyunsaturated Fatty Acid (PUFA) Theory of Schizophrenia
Author:
Preprint
Abstract
I present a theory of schizophrenia (SZ) that mechanistically explains its etiology, symptoms, pathophysiology, and treatment. SZ involves the chronic release of membrane polyunsaturated fatty acids (PUFAs) and their utilization for the synthesis of stress-induced plasticity agents such as endocannabinoids (ECBs). The causal event in SZ is prolonged stress during a sensitive period, which can induce prolonged and heritable changes. The physiological effect of the released PUFAs and their products is to disconnect neurons from their inputs and promote intrinsic excitability. I show that these effects can explain the positive, negative, cognitive, and mood symptoms of SZ, as well as the mechanisms of many known triggers of psychosis. The theory is supported by overwhelming evidence addressing lipids, immunity, ECBs, neuromodulators, hormones, neurotransmitters, and cortical parameters in SZ. It explains why antipsychotic drugs are effective against positive symptoms, and why they do not affect the other symptoms. Finally, I present promising treatment directions implied by the theory, including some that are immediately available.Keywords
All Related Versions
This publication has 301 references indexed in Scilit:
- In Vivo Availability of Cannabinoid 1 Receptor Levels in Patients With First-Episode PsychosisJAMA Psychiatry, 2019
- Endocannabinoids and energy homeostasis: An updateBioFactors, 2014
- Reduced Cortical Cannabinoid 1 Receptor Messenger RNA and Protein Expression in SchizophreniaArchives of General Psychiatry, 2008
- Cytosolic PLA2 genes possibly contribute to the etiology of schizophreniaAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2005
- Segregation of serotonin 5-HT2A and 5-HT3 receptors in inhibitory circuits of the primate cerebral cortexJournal of Comparative Neurology, 2000
- Mutations in the M1 region of the nicotinic acetylcholine receptor alter the sensitivity to inhibition by quinacrineCellular and Molecular Neurobiology, 1995
- An In Vivo Study of the Prefrontal Cortex of Schizophrenic Patients at Different Stages of Illness via Phosphorus Magnetic Resonance SpectroscopyArchives of General Psychiatry, 1995
- Transmembrane signaling through phospholipase C in human cortical membranesNeurochemical Research, 1993
- Elevated plasma prostaglandin E2 levels in schizophreniaJournal of Neural Transmission, 1989
- Potential therapeutic efficacy of inhibitors of human phospholipase A2 in septic shockInflammation Research, 1986